LABCARE NPI 1811615198

NPI Details

LABCARE is a clinical medical laboratory in Dallas, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. LABCARE NPI is 1811615198. The provider is registered as an organization entity type.
The provider Former Legal Business Name Is Labcare, Llc.

The provider's business location address is:

13601 PRESTON RD STE 360E
DALLAS, TX
ZIP 75240-903
Phone: (972) 807-7600

The provider's authorized official is Hamdan Dajeh .
The authorized official title is Owner and has the following contact phone number (980) 228-8103.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes (HCPCS:81435)
• Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants (HCPCS:81300)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants (HCPCS:81319)
• Test for detecting genes associated with inherited breast cancer-related disorders (HCPCS:81432)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants (HCPCS:81297)

The enumeration date for this NPI number is 8/22/2022 and was last updated on 9/1/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: